AustraliaBreaking News

Nagambie Resources (ASX:NAG) announced a $9 million reduction in total debt, marking a shift in the company’s financial structure.

ASML raised its full-year sales forecast, with net sales expected to be between 36 billion ($42.4 billion) to 40 billion this year. Europe's most valuable company's machinery is crucial for producing the Nvidia Corp. chips that are the backbone for training and running artificial intelligence models in data centers. Bloomberg's Charlotte Hughes-Morgan reports.

Xenitra (ASX:XEN) announced the 100% acquisition of Hong Kong Fukang Trading.

QEM (ASX:QEM) announced the strategic acquisition of past-producing fluorspar, tungsten, and niobium projects in Idaho.

Gucci sales fell, hurt by the conflict in the Middle East. Revenue at the Kering brand slid 8% on a comparable basis during the first quarter. Analysts were expecting a drop of 4.3%. Bloomberg Intelligence's Deborah Aitken breaks down the situation.

OD6 Metals (ASX:OD6) reported ultra-high-grade channel sampling results from the Horseshoe prospect at its Quinn Fluorspar Project.

PYC Therapeutics (ASX:PYC) advances its PYC-001 drug candidate to multiple-dose testing for blinding eye disease ADOA.

Omnia Metals (ASX:OM1) announced a multi-faceted strategic expansion into the United States' critical minerals sector.

Ovanti (ASX:OVT) raised $5.3 million to scale its global BNPL platform and AI-driven "Super App" strategy.

A Supreme Court justice has ordered Gina Rinehart’s Hancock Prospecting to pay royalties to two rival dynasties.

FDA granted Immutep (ASX:IMM) Orphan Drug Designation for eftilagimod alfa in soft tissue sarcoma.

Former IMF Chief Economist & Harvard University Professor Kenneth Rogoff believes it's naive to think it's mission accomplished in the Iran war. He adds that the current market sentiment is only a temporary respite. He speaks with Yvonne Man and David Ingles from the sidelines of the 'HSBC Global Investment Summit' in Hong Kong.